Quinolinyl-pyrrolopyrazoles

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S314000

Reexamination Certificate

active

10531237

ABSTRACT:
A compound according to formula II and the pharmaceutically acceptable salts thereof and the method of treating cancer in a patient in need thereof by administration of said compound.

REFERENCES:
patent: 2004/0106604 (2004-06-01), Beight et al.
patent: 0 531 901 (1993-03-01), None
patent: WO 02 094833 (2002-11-01), None
patent: 2004/048383 (2004-06-01), None
Anscher, New Eng J of Med, fol 328:1592-1598, Jun. 1993.
Artega J Clin Invest, vol. 92, pp. 2569-2576, 1993.
Artega, Cell Growth & Differentiation, vol. 4, pp. 193-201. Mar. 1993.□□
Dickson, Porc Natl Acad Sci, USA, vol. 84, pp. 837-841, Feb. 1987.
Daly, J of Cell Biochemistry, vol. 43, pp. 199-211, 1990.
King, J steroid Biochem, vol. 34, Nos. 1-6, pp. 133-139, 1989.
Welch, Proc Natl Acad Sci USA, vol. 87, pp. 7678-7682, Oct. 1990.
Walker, Eur J Cancer, vol. 28, No. 2/3, pp. 641-644, 1992.
Butta, Cancer Research, vol. 52, pp. 4261-4264, Aug. 1992.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Quinolinyl-pyrrolopyrazoles does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Quinolinyl-pyrrolopyrazoles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinolinyl-pyrrolopyrazoles will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3731193

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.